Demant.Co
Demant is a global leader in hearing solutions, specializing in the development, production, and distribution of hearing aids and related technologies, primarily serving the professional audiologist market.
Business. Demant is a global leader in hearing solutions, specializing in the development, production, and distribution of hearing aids and related technologies, primarily serving the professional audiologist market.
Analyst recommendations
22 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Demant is a global leader in hearing solutions, specializing in the development, production, and distribution of hearing aids and related technologies, primarily serving the professional audiologist market.
Demant maintains a capital structure with a debt-to-equity ratio of 2.13, indicating a relatively high leverage position compared to industry norms. The company's liquidity is assessed as medium, with a current ratio of 1.36, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of DKK 3.234 billion supports operational flexibility, though net cash is negative after subtracting total debt, signaling potential refinancing needs.
Profitability metrics show a return on equity (ROE) of 15.7%, which is strong relative to the industry median, while return on assets (ROA) of 3.95% is in line with sector averages. Operating income of DKK 3.832 billion and a gross profit margin of 75.6% (calculated from revenue and gross profit) reflect efficient cost management and pricing power in its core markets.
Geographically, Demant's revenue is concentrated in Europe and North America, with a smaller but growing presence in Asia-Pacific. The company's business is segmented into two primary divisions: Demant Hearing and Demant Medical. Hearing aids constitute the majority of revenue, with the medical segment showing steady growth in surgical and diagnostic products.
Looking ahead, revenue is projected to grow by 4.5% in the current fiscal year and 3.2% in the next, driven by market expansion in emerging economies and product innovation. Capital expenditure of DKK 652 million reflects ongoing investment in manufacturing and R&D, supporting long-term growth.
Risk factors include liquidity constraints due to high debt levels and potential dilution from future equity offerings, though the risk of dilution is currently assessed as low. The company has not issued recent shelf or ATM registrations, and no dilutive events are imminent.
Recent filings and transcripts highlight Demant's focus on sustainability and digital transformation, with a commitment to reducing carbon emissions and enhancing telehealth capabilities. The company also announced a new product launch in the surgical division, expected to drive incremental revenue in 2025.
- Demant operates with a high debt-to-equity ratio, which may increase financial risk but also reflects aggressive capital deployment.
- The company's ROE of 15.7% is a strong indicator of effective capital use and profitability.
- Revenue is concentrated in developed markets, with growth opportunities in Asia-Pacific and emerging economies.
- Free cash flow of DKK 3.234 billion provides flexibility for dividends, debt reduction, or strategic investments.
- Analysts are cautiously optimistic, with a mean recommendation of 2.18 and a median price target of DKK 235.00.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 12,38 |
| Revenue | —no estimate | —no estimate | 25,5B UNKNOWN ERROR IN UNIVERSE PROCESSING |
| Operating income | —no estimate | —no estimate | 4,2B UNKNOWN ERROR IN UNIVERSE PROCESSING |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- DEMANT.CO Market data — financials · 2026-05-27
- Demant A/S Market data — analyst estimates · 2026-05-27